Ida Micaily, MD, MS

My clinical and research focus spans gynecologic malignancies, with particular emphasis on addressing healthcare disparities and advancing drug development through both early- and late-phase clinical trials.

As co-leader of the Gynecologic Multidisciplinary Group at Jefferson Health, and leader of the Gynecologic Division within our Early Drug Development/Phase 1 Program, I play a pivotal role in shaping innovative cancer care. Our program takes a holistic and compassionate approach to treating ovarian, endometrial, and cervical cancers, integrating multidisciplinary expertise to deliver the most personalized and effective treatment possible.

I am deeply committed to disparities research, striving to improve access to care and clinical trials for underserved communities, particularly women of color, with the goal of enhancing outcomes for those affected by gynecologic cancers.

Medical School

MD, St. George’s University, Grenada, West Indies - 2016

Residency

Abington Jefferson Health, Abington, PA

Fellowship

Hematology/Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA

Additional Education

MS, Thomas Jefferson University, Philadelphia, PA, 2022

Post-Baccalaureate, University of Pennsylvania, Philadelphia, PA 2011